Statements (106)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Nell_Zink
gptkb:Too_Weird_to_Live,_Too_Rare_to_Die! |
| gptkbp:affects |
central nervous system
nicotinic acetylcholine receptors |
| gptkbp:appointed_by |
gptkb:spacecraft
gptkb:candy inhalation lozenges |
| gptkbp:can_lead_to |
gptkb:software
withdrawal symptoms increased tolerance increased cravings |
| gptkbp:caused_by |
dizziness
nausea vomiting headaches increased heart rate increased blood pressure |
| gptkbp:depicted_in |
e-cigarettes
|
| gptkbp:developed_by |
gptkb:drug
|
| gptkbp:enhances |
cognitive function
alertness |
| gptkbp:excretion |
urine
|
| gptkbp:has_impact_on |
mood
central nervous system |
| https://www.w3.org/2000/01/rdf-schema#label |
Nicotine
|
| gptkbp:is_a |
gptkb:drug
toxic substance |
| gptkbp:is_affected_by |
neurotransmitter systems
|
| gptkbp:is_associated_with |
gptkb:healthcare_organization
gptkb:drug cognitive decline mental health issues stroke mental health disorders heart disease respiratory diseases increased anxiety increased risk of diabetes increased risk of stroke |
| gptkbp:is_considered |
toxic
a stimulant a carcinogen a neurotoxin a psychoactive substance a health risk a drug of abuse a major health concern a public health challenge |
| gptkbp:is_found_in |
gptkb:drug
plants other plants e-cigarettes |
| gptkbp:is_involved_in |
reward pathways
|
| gptkbp:is_known_for |
affect appetite
its addictive properties affect dopamine levels affect heart rate variability affect serotonin levels affect sleep patterns affect stress response |
| gptkbp:is_linked_to |
gptkb:healthcare_organization
gptkb:hospital gptkb:historical_event gptkb:psychologist anxiety respiratory diseases various health risks chronic obstructive pulmonary disease premature aging impaired wound healing increased risk of addiction to other substances poor pregnancy outcomes |
| gptkbp:is_part_of |
smoking cessation programs
tobacco control policies tobacco products smoking culture public health discussions smoking-related diseases addiction treatment strategies tobacco harm reduction strategies |
| gptkbp:is_studied_in |
toxicology
pharmacology neuroscience potential therapeutic uses |
| gptkbp:is_subject_to |
gptkb:municipality
gptkb:Research_Institute taxation |
| gptkbp:is_used_in |
gptkb:spacecraft
gptkb:drug research studies insecticides nasal sprays inhalers vaping products smoking products smoking cessation products lozenges smoking cessation aids oral tobacco products |
| gptkbp:legal_issue |
most countries
|
| gptkbp:metabolism |
liver
|
| gptkbp:participated_in |
dopamine release
|
| gptkbp:regulates |
gptkb:FDA
|